KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Asset Utilization Ratio (2016 - 2025)

Travere Therapeutics' Asset Utilization Ratio history spans 13 years, with the latest figure at 0.64 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 50.7% year-over-year to 0.64; the TTM value through Dec 2025 reached 0.64, up 50.7%, while the annual FY2025 figure was 0.82, 142.69% up from the prior year.
  • Asset Utilization Ratio reached 0.64 in Q4 2025 per TVTX's latest filing, up from 0.57 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q4 2025 to a low of 0.11 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.29, with a median of 0.24 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 61.07% in 2022, then surged 137.01% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.2 in 2021, then dropped by 22.67% to 0.16 in 2022, then grew by 14.44% to 0.18 in 2023, then soared by 137.01% to 0.42 in 2024, then skyrocketed by 50.7% to 0.64 in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Asset Utilization Ratio are 0.64 (Q4 2025), 0.57 (Q3 2025), and 0.6 (Q2 2025).